Omicron might behave differently in US - Fauci

Wednesday, 22. December 2021 21:36

While the Omicron variant of the coronavirus has proven to be less severe than the Delta strain in two separate studies in Scotland and South Africa, it might spread and behave differently in the United States, US National Institute of Allergy and Infectious Diseases (NIAID) Director Dr. Anthony Fauci said on Wednesday.

During a daily press briefing, Fauci added that monoclonal antibody medicines developed by GlaxoSmithKline PLC and AstraZeneca plc are more likely to be effective versus Omicron than their counterparts developed by Eli Lilly and Co., and Regeneron Pharmaceuticals Inc.

"Small-molecule antivirals, such as molnupiravir, paxlovid, and remdesivir," are likely to retain the most of their efficiency against the new strain, Fauci concluded.

Related Links: 
Baha Breaking News (BBN) / BU